174 related articles for article (PubMed ID: 9816064)
1. Inhibitors of carbohydrate processing: A new class of anticancer agents.
Goss PE; Baker MA; Carver JP; Dennis JW
Clin Cancer Res; 1995 Sep; 1(9):935-44. PubMed ID: 9816064
[TBL] [Abstract][Full Text] [Related]
2. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies.
Goss PE; Reid CL; Bailey D; Dennis JW
Clin Cancer Res; 1997 Jul; 3(7):1077-86. PubMed ID: 9815786
[TBL] [Abstract][Full Text] [Related]
3. Structural investigation of the binding of 5-substituted swainsonine analogues to Golgi alpha-mannosidase II.
Kuntz DA; Nakayama S; Shea K; Hori H; Uto Y; Nagasawa H; Rose DR
Chembiochem; 2010 Mar; 11(5):673-80. PubMed ID: 20209559
[TBL] [Abstract][Full Text] [Related]
4. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.
Sebti SM; Hamilton AD
Oncogene; 2000 Dec; 19(56):6584-93. PubMed ID: 11426643
[TBL] [Abstract][Full Text] [Related]
5. Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms.
Shah N; Kuntz DA; Rose DR
Biochemistry; 2003 Dec; 42(47):13812-6. PubMed ID: 14636047
[TBL] [Abstract][Full Text] [Related]
6. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
Jung LL; Zamboni WC
Drug Resist Updat; 2001 Aug; 4(4):273-88. PubMed ID: 11998845
[TBL] [Abstract][Full Text] [Related]
7. Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis.
Dennis JW
Cancer Res; 1986 Oct; 46(10):5131-6. PubMed ID: 3093060
[TBL] [Abstract][Full Text] [Related]
8. Protein glycosylation in development and disease.
Dennis JW; Granovsky M; Warren CE
Bioessays; 1999 May; 21(5):412-21. PubMed ID: 10376012
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of N-linked oligosaccharide processing in tumor cells is associated with enhanced tissue inhibitor of metalloproteinases (TIMP) gene expression.
Korczak B; Dennis JW
Int J Cancer; 1993 Feb; 53(4):634-9. PubMed ID: 8436437
[TBL] [Abstract][Full Text] [Related]
10. Effects of the alpha-mannosidase inhibitors, 1,4-dideoxy-1,4-imino-D-mannitol and swainsonine, on glycoprotein catabolism in cultured macrophages.
Daniel PF; Newburg DS; O'Neil NE; Smith PW; Fleet GW
Glycoconj J; 1989; 6(2):229-40. PubMed ID: 2535594
[TBL] [Abstract][Full Text] [Related]
11. Structure of Golgi alpha-mannosidase II: a target for inhibition of growth and metastasis of cancer cells.
van den Elsen JM; Kuntz DA; Rose DR
EMBO J; 2001 Jun; 20(12):3008-17. PubMed ID: 11406577
[TBL] [Abstract][Full Text] [Related]
12. Different adhesion and migration properties of human HCV29 non-malignant urothelial and T24 bladder cancer cells: role of glycosylation.
Przybyło M; Lityńska A; Pocheć E
Biochimie; 2005 Feb; 87(2):133-42. PubMed ID: 15760705
[TBL] [Abstract][Full Text] [Related]
13. Increased antitumor efficacy by the combined administration of swainsonine and cisplatin in vivo.
Santos FM; Latorre AO; Hueza IM; Sanches DS; Lippi LL; Gardner DR; Spinosa HS
Phytomedicine; 2011 Sep; 18(12):1096-101. PubMed ID: 21763115
[TBL] [Abstract][Full Text] [Related]
14. Swainsonine is a useful tool to monitor the intracellular traffic of N-linked glycoproteins as a function of the state of enterocytic differentiation of HT-29 cells.
Houri JJ; Ogier-Denis E; Bauvy C; Aubery M; Sapin C; Trugnan G; Codogno P
Eur J Biochem; 1992 May; 205(3):1169-74. PubMed ID: 1577000
[TBL] [Abstract][Full Text] [Related]
15. Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3.
Tanaka Y; Kato J; Kohara M; Galinski MS
Antiviral Res; 2006 Oct; 72(1):1-9. PubMed ID: 16730076
[TBL] [Abstract][Full Text] [Related]
16. The effect of TNF-alpha on glycosylation pathways in bovine synoviocytes.
Yang X; Lehotay M; Anastassiades T; Harrison M; Brockhausen I
Biochem Cell Biol; 2004 Oct; 82(5):559-68. PubMed ID: 15499384
[TBL] [Abstract][Full Text] [Related]
17. An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells.
Nyormoi O; Mills L; Bar-Eli M
Cell Death Differ; 2003 May; 10(5):558-69. PubMed ID: 12728254
[TBL] [Abstract][Full Text] [Related]
18. Combretastatin A4-induced differential cytotoxicity and reduced metastatic ability by inhibition of AKT function in human gastric cancer cells.
Lin HL; Chiou SH; Wu CW; Lin WB; Chen LH; Yang YP; Tsai ML; Uen YH; Liou JP; Chi CW
J Pharmacol Exp Ther; 2007 Oct; 323(1):365-73. PubMed ID: 17646428
[TBL] [Abstract][Full Text] [Related]
19. Structural diversity of cytosolic free oligosaccharides in the human hepatoma cell line, HepG2.
Yanagida K; Natsuka S; Hase S
Glycobiology; 2006 Apr; 16(4):294-304. PubMed ID: 16381657
[TBL] [Abstract][Full Text] [Related]
20. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
